{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:48:15Z","timestamp":1778525295289,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20231367"],"award-info":[{"award-number":["BK20231367"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370195"],"award-info":[{"award-number":["82370195"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.modpat.2025.100919","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T23:33:05Z","timestamp":1760571185000},"page":"100919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma\/Waldenstr\u00f6m Macroglobulinemia From Marginal Zone Lymphoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Zhen","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ninghan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huimin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5123-813X","authenticated-orcid":false,"given":"Yujie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.modpat.2025.100919_bib1","doi-asserted-by":"crossref","first-page":"e827","DOI":"10.1016\/S2352-3026(20)30224-6","article-title":"Consensus treatment recommendations from the tenth International Workshop for Waldenstr\u00f6m Macroglobulinaemia","volume":"7","author":"Castillo","year":"2020","journal-title":"Lancet Haematol"},{"issue":"7","key":"10.1016\/j.modpat.2025.100919_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.modpat.2025.100919_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41375-022-01762-3","article-title":"Diagnostics in Waldenstr\u00f6m's macroglobulinemia: a consensus statement of the European Consortium for Waldenstr\u00f6m's Macroglobulinemia","volume":"37","author":"Dogliotti","year":"2023","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.modpat.2025.100919_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamaoncol.2016.5763","article-title":"Diagnosis and management of Waldenstr\u00f6m macroglobulinemia: mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016","volume":"3","author":"Kapoor","year":"2017","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100919_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMra2102568","article-title":"Marginal-zone lymphomas","volume":"386","author":"Rossi","year":"2022","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.modpat.2025.100919_bib6","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/ajh.27058","article-title":"Marginal zone lymphoma: 2023 update on diagnosis and management","volume":"98","author":"Cheah","year":"2023","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100919_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.modpat.2025.100919_bib8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","article-title":"MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma","volume":"39","author":"Martinez-Lopez","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100919_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.16088","article-title":"CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenstr\u00f6m macroglobulinaemia treated with ibrutinib","volume":"187","author":"Castillo","year":"2019","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.modpat.2025.100919_bib10","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","article-title":"The cellular origin and malignant transformation of Waldenstr\u00f6m macroglobulinemia","volume":"125","author":"Paiva","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2025.100919_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1096-8652(200008)64:4<275::AID-AJH7>3.0.CO;2-Y","article-title":"Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders","volume":"64","author":"D\u2019Arena","year":"2000","journal-title":"Am J Hematol"},{"issue":"25","key":"10.1016\/j.modpat.2025.100919_bib12","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.modpat.2025.100919_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/geno.1996.0632","article-title":"Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64)","volume":"38","author":"Miura","year":"1996","journal-title":"Genomics"},{"issue":"7","key":"10.1016\/j.modpat.2025.100919_bib14","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.4049\/jimmunol.154.7.3333","article-title":"RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family","volume":"154","author":"Miyake","year":"1995","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100919_bib15","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jmb.2011.09.020","article-title":"Crystal structures of mouse and human RP105\/MD-1 complexes reveal unique dimer organization of the toll-like receptor family","volume":"413","author":"Ohto","year":"2011","journal-title":"J Mol Biol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100919_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nsmb.2106","article-title":"An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1","volume":"18","author":"Yoon","year":"2011","journal-title":"Nat Struct Mol Biol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100919_bib17","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4049\/jimmunol.168.2.554","article-title":"Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines","volume":"168","author":"Zarember","year":"2002","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100919_bib18","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.4049\/jimmunol.1100198","article-title":"Anti-CD180 (RP105) activates B cells to rapidly produce polyclonal Ig via a T cell and MyD88-independent pathway","volume":"187","author":"Chaplin","year":"2011","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100919_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2119\/molmed.2014.00265","article-title":"Rewiring of sIgM-mediated intracellular signaling through the CD180 toll-like receptor","volume":"21","author":"Porakishvili","year":"2015","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.modpat.2025.100919_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cyto.b.21325","article-title":"CD180 expression in B-cell lymphomas: a multicenter GEIL study","volume":"90","author":"Mayeur-Rousse","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"4","key":"10.1016\/j.modpat.2025.100919_bib21","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2011.08605.x","article-title":"CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells","volume":"153","author":"Porakishvili","year":"2011","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100919_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/cyto.b.21331","article-title":"CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment","volume":"90","author":"Mestrallet","year":"2016","journal-title":"Cytometry B Clin Cytom"},{"issue":"1","key":"10.1016\/j.modpat.2025.100919_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jlb.65.1.43","article-title":"Anti-human RP105 sera induces lymphocyte proliferation","volume":"65","author":"Roshak","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.modpat.2025.100919_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107540","article-title":"MD-1 downregulation is associated with reduced cell surface CD180 expression in CLL","volume":"143","author":"Edwards","year":"2024","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.modpat.2025.100919_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2141.2005.05775.x","article-title":"Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes","volume":"131","author":"Porakishvili","year":"2005","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100919_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3923\/pjbs.2023.311.320","article-title":"Empirical study on exploring the role of CD180 and MD-1 prognostic indicators for the chronic lymphocytic leukaemia (CLL) disease","volume":"26","author":"Alotaibi","year":"2023","journal-title":"Pak J Biol Sci"},{"issue":"2","key":"10.1016\/j.modpat.2025.100919_bib27","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/0008-5472.CAN-18-0781","article-title":"TLR signaling is activated in lymph node-resident CLL cells and is only partially inhibited by ibrutinib","volume":"79","author":"Dadashian","year":"2019","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.modpat.2025.100919_bib28","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.3983","article-title":"A new score including CD43 and CD180: increased diagnostic value for atypical chronic lymphocytic leukemia","volume":"10","author":"Li","year":"2021","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.modpat.2025.100919_bib29","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1111\/ijlh.12824","article-title":"Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL","volume":"40","author":"Favre","year":"2018","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100919_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.18502","article-title":"Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenstr\u00f6m macroglobulinaemia","volume":"200","author":"Moreno","year":"2023","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100919_bib31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31768\/2312-8852.2017.39(4):291-298","article-title":"CD150 and CD180 are involved in regulation of transcription factors expression in chronic lymphocytic leukemia cells","volume":"39","author":"Gordiienko","year":"2017","journal-title":"Exp Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100919_bib32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3892\/mmr.2020.11242","article-title":"RP105 plays a cardioprotective role in myocardial ischemia reperfusion injury by regulating the Toll-like receptor 2\/4 signaling pathways","volume":"22","author":"Huang","year":"2020","journal-title":"Mol Med Rep"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:35:27Z","timestamp":1773290127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225002170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0893395225002170"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100919","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma\/Waldenstr\u00f6m Macroglobulinemia From Marginal Zone Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100919"}}